Gregory Bailey Biohaven Pharmaceutical Holding CO Ltd. (BHVN) insider trading activity

Gregory Bailey is of Biohaven Pharmaceutical Holding Co Ltd.. Currently has a direct ownership of 0 shares of BHVN, which is worth approximately $0. The most recent transaction as insider was on Oct 03, 2022, when has been sold 2,583,658 shares (Common Shares) at a price of $148.5 per share, resulting in proceeds of $383,673,213. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Gregory Bailey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 03 2022	SELL Sale (or disposition) back to the issuer	$383,673,213 $148.5 p/Share	2,583,658 Reduced 100.0%	0 Common Shares
Aug 19 2022	BUY Open market or private purchase	$5,625,520 $148.04 p/Share	38,000 Added 1.45%	2,583,658 Common Stock
Oct 23 2020	SELL Open market or private sale	$826,206 $79.42 p/Share	10,403 Reduced 0.41%	2,545,658 Common Shares
Oct 22 2020	SELL Open market or private sale	$1,956,682 $79.65 p/Share	24,566 Reduced 0.95%	2,556,061 Common Shares
Oct 19 2020	SELL Open market or private sale	$359,675 $78.98 p/Share	4,554 Reduced 0.18%	2,580,627 Common Shares
Oct 16 2020	SELL Open market or private sale	$295,642 $78.88 p/Share	3,748 Reduced 0.14%	2,585,181 Common Shares
Oct 12 2020	SELL Open market or private sale	$530,716 $78.87 p/Share	6,729 Reduced 0.26%	2,588,929 Common Shares

Also insider at

AGE

AgeX Therapeutics, Inc. Healthcare

Director

BHVN

Biohaven Ltd.

Director

Gregory Bailey

New Haven, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHVN shares.

Notify only if

Value

Insider Trading

Get notified when an Biohaven Pharmaceutical Holding CO Ltd. insider buys or sells BHVN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Biohaven Pharmaceutical Holding Co Ltd.

Track Activities on BHVN

Account